DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary
- 1 October 1993
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 3 (6) , 349-358
- https://doi.org/10.1046/j.1525-1438.1993.03060349.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A retrospective study of 370 borderline tumors of the ovary treated at the norwegian radium hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalitiesCancer, 1993
- Comparison between flow cytometry and image cytometry in ploidy distribution assessments in gynecologic cancerCytometry, 1992
- DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumorsGynecologic Oncology, 1989
- Clinical significance of abnormal nuclear DNA content in serous ovarian tumorsCancer, 1988
- Ploidy assessment of benign and malignant ovarian tumors by flow cytometry. A clinicopathologic studyCancer, 1987
- Tumor ploidy as a major prognostic factor in advanced ovarian cancerCancer, 1987
- Ovarian epithelial tumors of borderline malignancy: A clinical and pathologic study of 109 casesCancer, 1986
- Nuclear DNA content of borderline tumors of the ovary: Correlation with histology and significance for prognosisVirchows Archiv, 1986
- Borderline and malignant mucinous tumors of the ovary.Histologic criteria and clinical behaviorCancer, 1973
- DNA content of mucinous tumors of the ovaryAmerican Journal of Obstetrics and Gynecology, 1969